Skip to main content
. 2021 Jul 26;77(Suppl 2):S379–S384. doi: 10.1016/j.mjafi.2021.06.007

Table 2.

Association of antibody formation with clinical condition (N = 957).

IgG Antibody Unadjusted Odds ratio 95% CI Adjusted Odds ratio 95% CI
Age 1.03 1.03–1.04∗∗∗ 1.01 1.00–1.02∗
Sex
 F Reference Reference Reference Reference
 M 1.04 0.8–1.4 1.13 0.8–1.5
Days from onset of symptoms 1.2 1.1–1.2∗∗∗ 1.1 1.07–1.1∗∗∗
Clinical Severity
 Mild Reference Reference Reference Reference
 Moderate 5.4 3.7–7.9∗∗∗ 2.9 2–4.4∗∗∗
 Severity 12.7 5.9–26.3∗∗∗ 3.5 1.6–7.9∗∗
Co-morbidity
3.1
2.4–4∗∗∗
1.9
1.3–2.6∗∗∗
IgM Antibody
Age 1.03 1.02–1.04∗∗∗ 1.0 0.9–1.01
Sex
 F Reference Reference Reference Reference
 M 1.3 1.01–1.8∗ 1.5 1.1–2.1∗
Days from onset of symptoms 1.1 1.07–1.1∗∗∗ 1.05 1.03–1.08∗∗∗
Clinical Severity
 Mild Reference Reference Reference Reference
 Moderate 5.2 3.7–7.4∗∗∗ 3.3 2.3–4.8∗∗∗
 Severity 4.6 2.8–7.5∗∗∗ 1.9 1.01–3.4∗
Co-morbidity 2.9 2.2–3.8∗∗∗ 2.1 1.5–2.9∗∗∗

∗<0.05, ∗∗<0.01, ∗∗∗<0.001.